{"id":"W2202546386","doi":"10.1016/j.dld.2015.08.015","title":"Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study","year":2015,"lang":"en","type":"letter","venue":"Digestive and Liver Disease","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada); University of Calgary","funders":"","keywords":"Boceprevir; Medicine; Ribavirin; Hepatitis C virus; Internal medicine; Hepatitis C; Telaprevir; Virology; Hepatology; Simeprevir; Genotype; Gastroenterology; Virus; Biology; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001792833,0.0006376958,0.001747966,0.0001903961,0.0004205109,0.0007607724,0.0006932456,0.002639426,0.002356693],"category_scores_gemma":[0.003176846,0.0002965689,0.001606986,0.0003893555,0.00049632,0.0006927245,0.000221186,0.002585347,0.0004365661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001152297,"about_ca_system_score_gemma":0.001042517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001712921,"about_ca_topic_score_gemma":0.003432547,"domain_scores_codex":[0.9990824,0.0005438034,0.00009436776,0.00007956207,0.00007647762,0.0001233505],"domain_scores_gemma":[0.9976459,0.001296692,0.0002207671,0.0001004751,0.0001053706,0.0006307573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.561431,0.02516059,0.08499479,0.001272816,0.003721879,0.03809487,0.001013779,0.001056304,0.01464971,0.0008491821,0.02157089,0.2461842],"study_design_scores_gemma":[0.3410281,0.3334873,0.2575525,0.0004552362,0.007208878,0.02257521,0.001220807,0.003585834,0.003178491,0.001631941,0.02786007,0.0002155963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733136,0.006779029,0.0002712701,0.01381053,0.0008595258,0.0003912017,0.0005953594,0.00004016814,0.003939399],"genre_scores_gemma":[0.9832196,0.003041181,0.0005229065,0.009640042,0.001511009,0.0002456243,0.0003581129,0.00001263702,0.001448817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002639426,"threshold_uncertainty_score":0.009481549,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09978604887310835,"score_gpt":0.3315938769378718,"score_spread":0.2318078280647634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}